ArticleClinical and translational allergy2023

Omalizumab prevents respiratory illnesses in non-atopic chronic spontaneous urticaria patients: A prospective, parallel-group, pilot pragmatic trial.

George N Konstantinou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.